| 2003 |
MO25α/β forms a heterotrimeric complex with LKB1 and STRADα/β that functions as an upstream kinase (AMPKK) phosphorylating AMPK at Thr172; two AMPKK activities purified from rat liver were shown to contain LKB1, STRADα, and MO25α and could be immunoprecipitated with anti-LKB1 antibodies; catalytically active LKB1, STRAD, and MO25 are all required for full AMPK-activating activity. |
Biochemical purification from rat liver, immunoprecipitation, recombinant complex reconstitution, in vitro kinase assay, LKB1 knockout fibroblasts, HeLa cell reconstitution |
Journal of biology |
High |
14511394
|
| 2004 |
MO25α has two binding sites on opposite surfaces required for assembly into the complex with STRADα and LKB1; MO25α binds directly to a conserved Trp-Glu-Phe (WEF) sequence at the STRADα C-terminus, markedly enhancing STRADα binding to LKB1 and increasing LKB1 catalytic activity; LKB1 does not require T-loop phosphorylation to be activated by STRADα-MO25α; STRADα can bind ATP but this is not required for LKB1 activation. |
Point mutagenesis of MO25α and LKB1 cancer mutants, in vitro kinase assay, co-immunoprecipitation, protein interaction mapping |
Journal of cell science |
High |
15561763
|
| 2004 |
Crystal structure of MO25α reveals a helical repeat (Armadillo-like) fold; MO25α binds the STRAD C-terminal WEF motif via a hydrophobic pocket; mutagenesis confirmed the structural interface is functionally required for STRAD-LKB1 complex activity. |
X-ray crystallography of MO25α–STRADα peptide complex, mutagenesis |
Nature structural & molecular biology |
High |
14730349
|
| 2009 |
Crystal structure of the heterotrimeric LKB1-STRADα-MO25α core complex reveals that STRADα adopts a closed active-kinase conformation and binds LKB1 as a pseudosubstrate; MO25α stabilizes the active conformation of LKB1 by directly interacting with the LKB1 activation loop; activation is phosphorylation-independent and mediated allosterically. |
X-ray crystallography of the trimeric complex, structure-guided mutagenesis, functional validation |
Science |
High |
19892943
|
| 2009 |
MO25α interacts directly with the STE20-family kinase MST4, stimulating its translocation from the Golgi to the subapical membrane upon LKB1 activation; MST4 acts downstream of the LKB1/STRAD/MO25 complex specifically in brush border formation by phosphorylating Ezrin at T567. |
Co-immunoprecipitation of MO25α–MST4, live-cell imaging of Golgi-to-apical translocation, kinase assay (T567 phosphorylation), MST4 inhibition loss-of-function, epistasis analysis |
Developmental cell |
High |
19386264
|
| 2011 |
MO25α and MO25β bind directly to STE20-family kinases SPAK, OSR1, MST3, MST4, and YSK1 (beyond STRAD), inducing ~100-fold activation of SPAK/OSR1 and ~3–4-fold activation of MST3/MST4/YSK1; MO25-activated SPAK/OSR1 phosphorylate ion cotransporters NKCC1, NKCC2, and NCC at several sites; siRNA knockdown of MO25 in cells inhibits endogenous NKCC1 phosphorylation, rescued by re-expression of MO25α. |
In vitro kinase assays, binding interaction studies, siRNA knockdown with rescue, phospho-site identification by mass spectrometry |
The EMBO journal |
High |
21423148
|
| 2013 |
Crystal structure of MST4 kinase domain in complex with MO25 shows that MO25 binding rotates the MST4 αC helix toward the catalytic core, stabilizing it in an active position; MST4 kinase domain forms a homodimer required for trans-autophosphorylation; interface mutations disrupting MST4-MO25 interaction or homodimerization impair kinase activation and function in HEK293T cells. |
X-ray crystallography, interface mutagenesis, in vitro kinase assay, cell-based apoptosis assay |
Structure |
High |
23434407
|
| 2013 |
Crystal structure of MST3 catalytic domain in complex with MO25β reveals that MO25β stabilizes MST3 in a closed, active conformation via an interface involving Tyr223 of MO25β and Glu58/Ile71 of MST3; mutation of these residues prevents MO25β-mediated MST3 activation; MO25 activates GCK kinases (MST3, MST4, STK25, OSR1, SPAK) through a unified structural mechanism. |
X-ray crystallography, mutagenesis, in vitro kinase assay |
Biochemical and biophysical research communications |
High |
23296203
|
| 2014 |
Structural studies of MO25 in complex with GCK kinases (MST3, MST4, STK25, OSR1, SPAK) reveal a unified activation mechanism: MO25 stabilizes the active αC helix and A-loop conformation of GCK kinases; activation of LKB1 involves an additional layer where MO25 first activates pseudokinase STRAD which then activates LKB1; structures of MO25α-STK25 and MO25α-MST3 represent transition and fully activated states respectively. |
X-ray crystallography of multiple MO25-kinase complexes, structural comparison |
Journal of structural biology |
High |
24746913
|
| 2014 |
CAB39 (MO25/Cab39) differentially interacts with WNK4 and SPAK/OSR1 to enable a SPAK/OSR1-independent pathway: WNK4 in association with Cab39 can directly activate NKCC1; WNK4 possesses a PF2-like domain homologous to the SPAK/OSR1 CCT domain that mediates direct WNK4-NKCC1 interaction. |
Yeast two-hybrid, in vitro kinase assay, protein binding/modeling, functional cotransporter assays in Xenopus oocytes |
The Journal of biological chemistry |
Medium |
24811174
|
| 2013 |
Structure of zebrafish MO25 determined to 2.9 Å resolution reveals seven helical repeats with overall architecture very similar to human MO25, confirming structural conservation. |
X-ray crystallography, molecular replacement |
Acta crystallographica. Section F |
Medium |
23989145
|
| 2005 |
Long-chain acyl-CoA esters (LCACEs) inhibit LKB1/STRAD/MO25 complex activity toward AMPK (phosphorylation of Thr172) in a concentration-dependent, substrate-specific manner requiring both a long fatty chain and a CoA moiety, while not inhibiting LKB1/STRAD/MO25 activity toward the peptide substrate LKBtide. |
In vitro kinase assay with recombinant and purified liver LKB1/STRAD/MO25, substrate specificity controls |
American journal of physiology. Endocrinology and metabolism |
Medium |
15644453
|
| 2006 |
3-Phosphoglycerate (3-PG) stimulates LKB1-STRAD-MO25 activity specifically toward AMPK (not toward the peptide substrate LKBtide), allowing increased AMPK phosphorylation; ADP inhibits both AMPK and LKB1-STRAD-MO25. |
In vitro kinase assay with purified LKB1-STRAD-MO25, metabolite panel screen |
American journal of physiology. Endocrinology and metabolism |
Medium |
16985256
|
| 2024 |
In the kidney distal convoluted tubule, Cab39 (and its paralog Cab39l) is required for SPAK/OSR1 localization to the apical membrane with NCC; double knockout of both Cab39 isoforms causes SPAK and OSR1 to become confined to intracellular puncta, abolishes NCC phosphorylation, and produces a Gitelman syndrome-like phenotype with loss of NCC function. |
Tamoxifen-inducible NCC-specific and global Cab39/Cab39l knockout mice, western blot, immunofluorescence, electrolyte analysis |
Hypertension |
High |
38258567
|
| 2026 |
In the absence of both Cab39 isoforms and KS-WNK1, phosphorylated SPAK still accumulates in cytoplasmic condensate puncta distinct from canonical WNK bodies; these puncta are p62-positive and ubiquitin-negative (sequestering, not degrading); their formation requires active upstream kinase phosphorylation. This demonstrates that Cab39 normally promotes SPAK translocation from condensates to the apical membrane for NCC phosphorylation. |
Triple-knockout mice (Cab39/Cab39l/KS-WNK1), immunoblotting, immunofluorescence, high/low K+ diet manipulation |
American journal of physiology. Renal physiology |
Medium |
41903110
|
| 2018 |
C-terminal serine phosphorylation within the conserved WEWS motif of SPAK and OSR1 enhances their binding to MO25; this phosphorylation is carried out by WNK kinases in vitro and in cells; mutagenesis identified key MO25 residues required for binding and activation of SPAK and OSR1. |
In vitro kinase assay, mutagenesis, binding studies, cell-based phosphorylation assay |
Biochemical and biophysical research communications |
Medium |
30060950
|
| 2022 |
Intracellular midkine (MDK) interacts with LKB1 and STRAD to disrupt the LKB1-STRAD-MO25 complex, thereby decreasing LKB1 activity and dampening basal and stress-induced (glucose starvation or 2-DG) AMPK activation. |
Co-immunoprecipitation, protein interaction mapping, AMPK activity assay, glucose starvation/2-DG stimulation |
Cell death & disease |
Medium |
35487917
|
| 2011 |
miR-451 directly targets the CAB39 3'UTR (confirmed by luciferase reporter assay), reducing CAB39 protein expression and consequently suppressing the PI3K/AKT pathway in glioma cells. |
3'UTR luciferase reporter assay, western blot, miR-451 mimic transfection, subcutaneous xenograft |
International journal of oncology |
Medium |
22179124
|
| 2023 |
CAB39 promotes cisplatin resistance in bladder cancer through the LKB1-AMPK-LC3 pathway: CAB39 knockdown sensitizes cisplatin-resistant cells; CAB39 overexpression has the opposite effect; downstream knockdown of LKB1 revealed LKB1 is required; the pathway enhances autophagy to maintain mitochondrial health and reduce ROS levels. |
Proteomic identification, CAB39 knockdown/overexpression, downstream gene knockdown epistasis (11 genes tested), in vivo xenograft, autophagy flux assay |
Free radical biology & medicine |
Medium |
37726090
|
| 2018 |
In Drosophila Malpighian tubules, Mo25 enhances the activity of the WNK downstream kinase Fray (fly SPAK/OSR1 homolog) in vitro; Mo25 knockdown in the tubule decreases transepithelial ion flux under stimulated but not basal conditions; Mo25 and chloride cooperate: Mo25 overexpression with chloride-insensitive WNK increased ion flux, whereas overexpression with wild-type WNK did not. |
In vitro kinase assay (Drosophila Mo25 + Fray), transgenic Drosophila knockdown/overexpression, intracellular chloride sensor, transepithelial flux assay |
Journal of the American Society of Nephrology |
Medium |
29602832
|
| 2016 |
In hypertensive rat brains following ischemic stroke, upregulated Cab39 is associated with increased NKCC1 phosphorylation through the WNK-Cab39-NKCC1 signaling axis, without increases in SPAK or OSR1. |
Western blot, co-immunoprecipitation (WNK-NKCC1 complex), NKCC1 inhibitor (bumetanide) in vivo treatment |
Journal of cerebral blood flow and metabolism |
Low |
27798271
|
| 2024 |
STRAD-binding small molecule compounds can activate LKB1 kinase activity, demonstrating that the MO25-STRAD-LKB1 complex can be pharmacologically activated through STRAD; this produces target-dependent anti-cancer effects in cancer cell lines. |
Small molecule screen, LKB1 kinase activity assay, cancer cell line functional assay |
bioRxivpreprint |
Low |
bio_10.1101_2024.12.17.628051
|
| 2022 |
miR-22 targets CAB39 in valvular interstitial cells; miR-22 overexpression reduces CAB39 expression, decreases catalytic activity of the CAB39-LKB1-STRAD complex, exacerbates changes in the AMPK-mTOR signaling pathway, and accelerates VIC calcification; miR-22 inhibition has the opposite effect. |
Adenovirus-mediated gain/loss of function, western blot, luciferase reporter (implied by target identification), calcium deposition assay, ALP activity |
Cellular and molecular life sciences |
Low |
35190902
|
| 2020 |
CAB39 promotes GLUT1 translocation to the plasma membrane and glucose uptake in a PI3K/AKT-pathway-dependent manner in lung cancer cells; this is regulated upstream by miR-451 which targets CAB39 mRNA. |
Immunofluorescence, flow cytometry (GLUT1 membrane localization and glucose uptake), bidirectional genetic manipulation (overexpression/knockdown) of CAB39, miR-451 and PI3K/AKT pathway components |
Therapeutic advances in chronic disease |
Low |
32994913
|